|Bid||181.00 x 1100|
|Ask||180.13 x 800|
|Day's range||174.02 - 184.41|
|52-week range||16.41 - 331.68|
|Beta (5Y monthly)||1.47|
|PE ratio (TTM)||N/A|
|Earnings date||01 Mar 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||300.75|
Dr. Shereef Elnahal, University Hospital CEO, Former NJDOH Commissioner, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on coronavirus vaccines.
A proposal currently before the World Trade Organization would waive patent rights on COVID-19 vaccines and treatments in an effort to help low-income nations. Several top Democrats appear to support the move, although the Biden administration has yet to state a position publicly. Despite the push, the president may be hesitant to override patents for pharmaceuticals.
Investors hungry for stocks that could make big movements in short time spans know that the biotech industry is full of them. This company is the first to submit an application to the Food and Drug Administration for a new drug designed to slow the progress of Alzheimer's disease.